Laurel Wealth Planning LLC Abbott Laboratories Transaction History

Laurel Wealth Planning LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $22,965 - $27,758	-225 Reduced 14.45%	1,332 $145,000
Q1 2022 Apr 28, 2022	BUY	$114.02 - $139.04 $171,030 - $208,560	1,500 Added 2631.58%	1,557 $184,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $5,016 - $5,549	-43 Reduced 43.0%	57 $7,000
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $4,548 - $5,354	43 Added 75.44%	100 $12,000
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $5,985 - $6,521	57 New	57 $6,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Laurel Wealth Planning LLC, based on Form 13F filings with the SEC.

Stay updated on Laurel Wealth Planning LLC with notifications on news.